• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: September 2020

Finance

Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for advanced biologics

September 28, 2020 Microbiome Times

Arranta Bio (“Arranta”), a leading microbiome contract development and manufacturing organization (CDMO), today announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility. Arranta is investing more than $100M in 2020 to […]

Editor's Choice

First Published Clinical Trial Using Live Biotherapeutic Candidate In COVID-19 Patients Suggests Role In Improving Outcomes

September 25, 2020 Microbiome Times

ExeGi Pharma LLC, a U.S.-based company focused on developing and commercializing products targeting the human microbiome, including live biotherapeutic products (LBPs), announced today the results of a 70-patient clinical trial evaluating a new biologic drug […]

Finance

Chr. Hansen acquires Jennewein Biotechnologie GmbH to enter and lead the high-growth Human Milk Oligosaccharides market

September 24, 2020 Microbiome Times

Chr. Hansen Holding A/S (“Chr. Hansen”) has entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH (“Jennewein”), which is a leading player in the Human Milk Oligosaccharides (“HMO”) market The […]

Pharma & Human Health

Micreos initiates clinical trial to evaluate world’s first endolysin-drug as a therapy for Atopic Dermatitis

September 23, 2020 Microbiome Times

Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study to assess the safety and efficacy of XZ.700 in patients with mild to […]

Finance

Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases

September 23, 2020 Microbiome Times

Siolta Therapeutics, a clinical-stage biotech company, announced today it has raised $30M in a series B investment round to support the clinical development of its lead product, STMC-103H. The series B funding involved participation from […]

Finance

DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics

September 22, 2020 Microbiome Times

The DuPont Human Microbiome Venture today announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health. Over the past […]

Pharma & Human Health

New live biotherapeutics will require regulatory and scientific innovation: The importance of a defined regulatory framework

September 17, 2020 Microbiome Times

The Pharmabiotic Research Institute (PRI), Europe’s only regulatory expertise centre for the development of microbiome-based drug products, has announced the publication of a review titled “Live biotherapeutic products: the importance of a defined regulatory framework”. […]

Pharma & Human Health

A bifidobacterial protein that can reduce inflammation in COVID-19 found by a RUDN geneticist

September 17, 2020 Microbiome Times

A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in […]

Pharma & Human Health

Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results

September 16, 2020 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) announced that it has obtained correspondence from the Office of Vaccines Research and Review of the U.S. Food and Drug Administration (FDA) regarding the Company’s plans to submit a Biologics […]

Pharma & Human Health

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial for the Treatment of Obesity and Metabolic Diseases

September 14, 2020 Microbiome Times

LNC Therapeutics, a French biotech company harnessing the properties of keystone single-strain bacteria to develop ground-breaking microbiome-based drugs, today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) […]

Phytobiome & Environment

Researchers receive $3 million NSF grant to ‘understand the rules of life’ through microbiome research.

September 4, 2020 Microbiome Times

A research team led by the University of Oklahoma has received a $3 million National Science Foundation grant to “understand the rules of life” through microbiome research. Microbiomes, a collection of microbes in a specific […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter